 This review evaluates prophylactic and therapeutic vaccine approaches against Epstein-Barr virus, EBV, infection, as well as immunotherapeutic strategies for EBV-associated malignancies, with the expectation that these emerging strategies will improve vaccine development and enhance the efficacy of novel treatments. This article was authored by Vijayendra Dasari, D-Bottomsinner, Michelle A. Nella, and others.